Moderna CFO nets shares from RSU vesting

Moderna, Inc. Chief Financial Officer James M. Mock reported routine equity compensation activity.

Rhea-AI Filing Summary

Moderna, Inc. Chief Financial Officer James M. Mock reported routine equity compensation activity. On April 2, 2026, 1,453 restricted stock units converted into an equal number of common shares. These units vest over time, with 25% having vested on October 5, 2023 and the remainder in twelve equal quarterly installments.

To cover tax withholding obligations tied to this vesting, 703 common shares were withheld at $50.03 per share, rather than sold in the open market. As a result, Mock’s direct holdings increased on a net basis, leaving him with 57,748 common shares and 2,906 restricted stock units directly owned after the transactions.

Insider Trade Summary

1,453 shares exercised/converted

Exercise 3 txns

Insider Mock James M

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	1,453	$0.00	$0.00
Exercise	Common Stock	1,453	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	703	$50.03	$35K

Holdings After Transaction: Restricted Stock Units — 2,906 contracts (Direct); Common Stock — 57,748 shares (Direct)

Footnotes (3)

1. F1. Restricted stock units convert into common stock on a one-for-one basis.
2. F2. Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.
3. F3. 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.

Key Figures

RSUs converted: 1,453 shares Shares withheld for tax: 703 shares Tax withholding price: $50.03 per share +4 more

7 metrics

RSUs converted 1,453 shares Restricted stock units converting into common stock on April 2, 2026

Shares withheld for tax 703 shares Common shares withheld to satisfy tax obligations at vesting

Tax withholding price $50.03 per share Price applied to 703 withheld shares

Common shares after transactions 57,748 shares Direct Moderna common stock held after April 2, 2026

RSUs remaining 2,906 units Restricted stock units directly held after the conversion

RSU initial vest 25% Portion of RSU award that vested on October 5, 2023

Remaining vesting pattern 12 quarterly installments Schedule for the remaining RSU vesting after October 5, 2023

Key Terms

Restricted Stock Units, tax withholding obligations, Exercise or conversion of derivative security, Payment of exercise price or tax liability by delivering securities, +1 more

5 terms

Restricted Stock Units financial

"Restricted stock units convert into common stock on a one-for-one basis."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations"

Exercise or conversion of derivative security financial

"transaction_code_description": "Exercise or conversion of derivative security""

Payment of exercise price or tax liability by delivering securities financial

"transaction_code_description": "Payment of exercise price or tax liability by delivering securities""

quarterly installments financial

"the remainder vesting in twelve (12) equal quarterly installments thereafter."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Moderna (MRNA) disclose for CFO James Mock?

Moderna disclosed that CFO James Mock had 1,453 restricted stock units convert into common stock on April 2, 2026. In connection with this vesting, 703 common shares were withheld to satisfy tax obligations, resulting in a routine net increase in his share ownership.

How many Moderna (MRNA) shares does CFO James Mock hold after this Form 4?

Following the April 2, 2026 transactions, CFO James Mock directly holds 57,748 shares of Moderna common stock. He also directly holds 2,906 restricted stock units, which are scheduled to vest over time according to the award’s quarterly vesting schedule.

Were any of CFO James Mock’s Moderna (MRNA) transactions open-market sales?

No open-market sales were reported. The Form 4 shows shares withheld under code F, representing 703 common shares withheld at $50.03 each to cover tax withholding obligations from RSU vesting, rather than discretionary sales on the open market.

What does the RSU vesting schedule look like for Moderna (MRNA) CFO James Mock?

The restricted stock unit award vested 25% of its shares on October 5, 2023. The remaining units vest in twelve equal quarterly installments thereafter, creating a structured, time-based vesting pattern that periodically converts RSUs into Moderna common shares.

How many restricted stock units did Moderna (MRNA) CFO James Mock have before and after this vesting?

On April 2, 2026, 1,453 restricted stock units converted into common stock. After this conversion, he directly holds 2,906 restricted stock units, continuing to provide future scheduled equity vesting under the award’s terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/06/2026 - 04:45 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mock James M

(Last) (First) (Middle)

C/O MODERNA, INC.

325 BINNEY STREET

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Moderna, Inc. [ MRNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/02/2026		M(1)		1,453	A	(1)	58,451	D
Common Stock	04/02/2026		F(2)		703	D	$50.03	57,748	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	04/02/2026		M(1)			1,453	(3)	(3)	Common Stock	1,453	$0	2,906	D

Explanation of Responses:

1. Restricted stock units convert into common stock on a one-for-one basis.

2. Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units.

3. 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.

	/s/ James Dillon, As Attorney-in-Fact	04/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)